McKesson announced that Brian S. Tyler, Ph.D., has been appointed president and chief operating officer, McKesson Corporation, effective August 2, 2018. Tyler will report to John Hammergren, chairman and chief executive officer, and will become a member of the executive committee.
“Brian is ideally suited to lead McKesson’s global operations based on his deep industry knowledge, outstanding track record as a business leader, and his commitment to operational excellence and customer success,” said Hammergren. “His broad experience as the president of multiple McKesson businesses provides him with the ideal background and perspective to help lead McKesson’s strategic initiative and drive long-term growth.”
Previously Chairman of the Management Board, McKesson Europe, Tyler has also served as president of McKesson North American Pharmaceutical Distribution and Services, McKesson U.S. Pharmaceutical, McKesson Medical-Surgical and McKesson Specialty Health, as well as executive vice president of corporate strategy and business development. His direct reports will include:
- President, McKesson U.S. Pharmaceutical and Specialty Health
- President, McKesson Medical-Surgical
- CEO, McKesson Canada
- President, McKesson Prescription Technology Solutions (MRxTS)
- President, Transformation Initiatives
- Chairman, Management Board, McKesson Europe
Tyler earned his Ph.D. and M.A. from the University of Chicago, Department of Economics in 1994, where he studied under a grant from the National Science Foundation, and earned his B.A. in economics with high honors from University of California Santa Cruz in 1989.
McKesson also announced today that Nick Loporcaro, president of McKesson’s U.S. Pharmaceutical and Specialty Solutions segment, has decided to leave McKesson to pursue other opportunities. Upon Loporcaro’s departure on August 10, Tyler will lead this segment directly until Loporcaro’s replacement has been named.
“Nick is a talented executive and we know he will accomplish great things in his next chapter,” said Hammergren. “He has led McKesson Canada, McKesson Specialty Health and most recently, the combined U.S. Pharmaceutical and Specialty Health business. We thank him for his many contributions to McKesson and wish him the greatest success.”